Inomata Takenori, Mashaghi Alireza, Di Zazzo Antonio, Lee Sang-Mok, Chiang Homer, Dana Reza
Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Cornea. 2017 Apr;36(4):491-496. doi: 10.1097/ICO.0000000000001127.
To delineate and compare the kinetics of corneal angiogenesis after high-risk (HR) versus low-risk (LR) corneal transplantation.
In mice, intrastromal sutures were placed in the recipient graft bed 2 weeks before allogeneic transplantation to induce angiogenesis and amplify the risk of graft rejection. Control (LR) graft recipients did not undergo suture placement, and thus the host bed remained avascular at the time of transplantation. Graft hemangiogenesis and opacity scores were evaluated for 8 weeks by slit-lamp biomicroscopy. Immunohistochemistry was used to measure CD31 (blood vessels) and LYVE-1 (lymphatic vessels) cells.
Biphasic kinetics were observed for hemangiogenesis in both HR and LR transplant recipients using clinical and immunohistochemical assessments. The biphasic kinetics were composed of a rise-fall (phase 1) followed by a second rise (phase 2) in the degree of vessels. Compared with LR recipients, HR recipients showed higher hemangiogenesis (whole cornea and graft) throughout 8 weeks. Analyzing grafts revealed sustained presence of lymphatic vessels in HR recipients; however, lymphatic neovessels regressed in LR recipients 2 weeks posttransplantation. In contrast to HR host beds, the LR host bed microenvironment cannot sustain the growth of lymphatic neovessels in allografts, whereas it can sustain continued hemangiogenesis.
The sustained presence of lymphatic vessels in HR host beds can facilitate host immunity against allografts and is likely associated with ongoing higher risk of rejection of these grafts in the long term, suggesting that therapeutic interventions targeting inflammation and lymphatic vessels need to be sustained long term in the HR corneal transplant setting.
描述并比较高风险(HR)与低风险(LR)角膜移植后角膜血管生成的动力学。
在小鼠中,于同种异体移植前2周在受体植床内放置基质内缝线以诱导血管生成并增加移植排斥风险。对照(LR)移植受体未进行缝线放置,因此在移植时宿主床保持无血管状态。通过裂隙灯生物显微镜检查评估移植的血管生成和混浊评分8周。免疫组织化学用于测量CD31(血管)和LYVE-1(淋巴管)细胞。
使用临床和免疫组织化学评估,在HR和LR移植受体中均观察到血管生成的双相动力学。双相动力学由血管程度的上升-下降(第1阶段)随后的第二次上升(第2阶段)组成。与LR受体相比,HR受体在整个8周内显示出更高的血管生成(全角膜和移植片)。分析移植片显示HR受体中淋巴管持续存在;然而,LR受体在移植后2周淋巴管新生血管消退。与HR宿主床相反,LR宿主床微环境不能维持同种异体移植中淋巴管新生血管的生长,而它可以维持持续的血管生成。
HR宿主床中淋巴管的持续存在可促进宿主对同种异体移植的免疫,并且可能与这些移植长期持续存在的更高排斥风险相关,这表明在HR角膜移植环境中,针对炎症和淋巴管的治疗干预需要长期维持。